SARS (Severe Acute Respiratory Syndrome) “viral pneumonia” Sejal Patel December 6 th, 2004.

Slides:



Advertisements
Similar presentations
Outbreak Investigation Severe Acute Respiratory Syndrome SARS April 2003.
Advertisements

SARS Cases Worldwide Reported to WHO as of June 6, 2003 China (5329) Singapore (206) Hong Kong (1750) Vietnam (63) Canada (219) U.S. (68) Europe: 8 countries.
Scientific Name: Ebola Virus
 SARS, also known as Severe Acute Respiratory Syndrome, is a dangerous virus that can cause several symptoms and even death. Scientists believe that.
Ebola Virus Disease. EVD Description Hemorrhagic fever with case fatality rate up to 90% Endemic areas: Central and West Africa Wildlife reservoir: bats.
The Deadly African Virus Presented by Claudia Hacker
Influenza H5N1 By Steven Yi. Contents Contents 1. Overview 2. History 3. Attachment 4. Entry 5. Replication 6. Lytic Cycle 7. Diagnosis 8. Treatment.
Severe Acute Respiratory Syndrome
Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.
World Health Organization, 15 June 2003
Severe Acute Respiratory Syndrome (SARS) Presented by Parth Dave & Kuan-Mei Lin December 2, 2005.
Modeling Lessons Learned from the SARS Outbreak Paul A. Dreyer Jr., Ph.D. Associate Mathematician RAND.
DISEASE AND PANDEMICS Brijesh Patel.
Influenza Sara Finestone April 8, The influenza virus causes 3-5 million cases of severe illness and up to 500,000 deaths annually.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
Influenza Ieuan Davies. Signs and Symptoms Influenza is an acute, viral respiratory infection. Fever, chills, headache, aches and pains throughout the.
Viral Infections of the Respiratory System.  Common cold (rhinitis)  Pharyngitis  Tonsilitis  Sinusitis & otitis media  Croup (acute laryngotracheobronchitis)
Poliovirus By: Connor Nash.
J. Trembley SARS: SEVER ACUTE RESPIRATORY SYNDROME.
DR MOHAMMED ARIF. ASSOCIATE PROFESSOR. CONSULTANT VIROLOGIST. HEAD OF THE VIROLOGY UNIT. Viral infection of the respiratory tract -- 2.
Ebola virus  The Ebola virus causes an acute, serious illness which is often fatal if untreated.  The most severely affected countries are: Guinea,
Severe Acute Respiratory Syndrome (SARS) Michael Leonard.
SARS ( Severe Acute Respirator Syndrome ). What is SARS? Severe acute respiratory syndrome (SARS) is a respiratory illness that has recently been reported.
PART IV: The Disease.
Rotaviruses Kaemwich Jantama Chemical Engineering.
Traveling Fever The following slides represent a realistic public health crisis event and you are charged with developing first messages for the public.
Viruses Chapter 19. A Borrowed Life Virus: an infections particle incapable of replicating outside of a cell, which consists of an RNA or DNA genome enclosed.
“He who has a why to live can bear almost any how.”
Bashaer Mohammedsaleh.  Middle East Respiratory Syndrome Coronavirus.  Causes Respiratory failure  With small number of reported cases, info about.
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
SARS: Protecting Workers. OSHA Guidance for Employers on Severe Acute Respiratory Syndrome (SARS) Potentially deadly respiratory disease Potentially deadly.
Viral Infections of the Respiratory System
SARS: Protecting Workers. OSHA Guidance for Employers on Severe Acute Respiratory Syndrome (SARS) Potentially deadly respiratory disease Potentially deadly.
SARS. What is it? SARS stands for severe acute respiratory syndrome. It is a respiratory disease caused by the SARS coronavirus.
Clinical Aspects of Severe Acute Respiratory Syndrome (SARS), 2003 John A. Jernigan, MD, MS For the SARS Clinical/Infection Control Investigative Team.
EBOLA HAEMORRHAGIC FEVER – BLEEDING FEVER 7NEWS EBOLA UPDATE.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
THE SARS VIRUS GENOME The Quick and the Dead?. SARS Severe Acute Respiratory Syndrome First identified in Guangdong Province, China Mortality 3-6% (45-63%
Viral Infections of the Respiratory System.  Common cold (rhinitis).  Sinusitis & otitis media.  Pharyngitis & tonsillitis.  Croup (acute laryngotracheobronchitis).
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
Jeremy Buige 2B.
How SARS Works. Originally, the World Health Organization (WHO) defined severe acute respiratory syndrome (SARS) as an "atypical pneumonia of unknown.
 Initial symptoms are flu like and could include- fever, myalgia, lethargy and/or gastrointestinal symptoms, cough, sore throat and other non- specific.
Influenza Causative Agent Orthomyxovirus Influenza A virus
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
SAS-Coronavirus: Diagnosis, Antibody Responses and Biosafty Conserns Cheng Cao Beijing Institute of Biotechnology, China.
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
Epidemiology. Epidemiological studies involve: –determining etiology of infectious disease –reservoirs of disease –disease transmission –identifying patterns.
Viral Infections of the Respiratory System.  Common cold (rhinitis)  Pharyngitis & tonsillitis.  Sinusitis & otitis media.  Croup (acute laryngotracheobronchitis).
HEALTH FORUM GASTEIN Crisis management and health policy for SARS and influenza control EUROPEAN UNION COOPERATION ON SARS CONTROL George Gouvras Health.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Superv. : Dr. Gomaa Abdelrahim Abdullalim By Khaled Al-Duraimeeh Abdullah Al-Sgair Majmaah University Collage of science in Al- Zulfi Medical.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
Severe Acute Respiratory Syndrome (SARS) Lydia Ho & Rui Yang BISC 209 Professor Mary Allen.
The Origin and Evolution of SARS Dept. of Microbiology, Faculty of Medicine, The University of Hong Kong The First Affiliated Hospital, Guangzhou Med.
SARS Severe Acute Respiratory Syndrome Jeffrey S. Duchin, M.D. Chief, Communicable Disease Control, Epidemiology and Immunization Section, Public Health.
Orthomyxoviridae Is enveloped virus, helical nucleocapsid
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
Severe Acute Respiratory Syndrome (SARS)
VIRAL INFLUENZA.
Severe Acute Respiratory Syndrome (SARS)
Medical Virology Lower Respiratory Tract Infections
Severe Acute Respiratory Syndrome (SARS) : Treatment and prophylaxis with Reactive Oxidizers Species preparations. Dmitri Popov. PhD, Radiobiology.
Severe Acute Respiratory Syndrome (SARS)
“He who has a why to live can bear almost any how.”
Coronaviruses Co Vs..
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
Presentation transcript:

SARS (Severe Acute Respiratory Syndrome) “viral pneumonia” Sejal Patel December 6 th, 2004

Where SARS was first found!  In a health care worker  In Guangdong Province, China.  In November,  SARS-CoV Urbani strain named after Dr. Carlo Urbani (WHO) notified WHO of unusual respiratory disease in patient (index patient) in Hanoi.

SARS Taxonomy Scientific Classification Group IV: Positive Sense Single Stranded RNA (“Nested” viruses) Order: Nidovirales (“Nested” viruses) Family: Coronaviridae Genus: Coronavirus Species: SARS coronavirus (SARS –CoV, Urbani strain) Hosts: Vertebrates ©McGraw-Hill, Inc.2005 Courtesy of Dr. Alan Cann.

Coronaviridae(s) 2 genus 1. Coronavirus (SARS-CoV) * Previously Unknown 2. Torovirus(Equine torovirus) Pathogenesis proven by Koch’s Postulate on Monkeys Coronavirus * healthy masked palm civets (paguma larvata) * China, Hong Kong, Singapore, Hanoi, and Toronto. * single stranded RNA (+ssRNA); encodes five major proteins maybe even more. * responsible for the death of more than 800 patients in over 27 countries. Courtesy of Dr. Alan Cann.

Coronavirus Pathogenesis “The envelope carries three glycoproteins: S - Spike protein: receptor binding, cell fusion, major antigen E - Envelope protein: small, envelope-associated protein M - Membrane protein: transmembrane - budding & envelope formation In a few types, there is a third glycoprotein: HE - Haemagglutinin-esterase The genome is associated with a basic phosphoprotein, N.” Courtesy of Dr. Alan Cann.

Coronavirus Pathogenesis cont…, Courtesy of Dr. Alan Cann. enters via endocytosis & membrane fusion + sense genome is translated to produce viral polymerase Viral polymerase produces full length – sense strand (poorly understood step) - sense strand used as a template to produce mRNA (monocistronic), “nested set” of transcripts assembled in the golgi apparatus and transport using secretory nature and released. REPLICATION OCCURS IN CYTOPLASM

Symptoms and Diagnostic Tests Initial Symptoms: fever of о F or higher, headaces, body aches, and malaise. Week Later: dry cough, difficulty breathing and severe diarrhea are seen in patients. Recovery: starts after 5 to 6 days  Early Diagnosis:  patient is given antibiotics, antiviral, and steroids used for atypical pneumonia.  Patient is are quarantined in specially ventilated rooms.  Laboratory tests:  RT-PCR (reverse transcription-polymerase chain reaction) assay  Detection of SARS-CoV RNA  EIA (enzyme immunoassay)  Detection of serum antibody to SARS-CoV RNA  Enzyme-linked immunosorbent assays (ELISA)  Detects antibodies against the virus produced in response to infection

Treatment and Prevention  No standard treatment yet  Patients receive combination therapy  effective antiviral and steroid (Lopinavir/ritonavir plus ribavirin)  Prevention  Isolation  Sterilization of area occupied by SARS patients  Caution and extra precautionary measure taken by medical workers and doctors.  Vaccines  According to the SAVI researchers 3 vaccines are possible to be used in the future: Whole killed vaccine, adenovirus vector, and recombination spike protein.( a bit more later in the presentation.)

Epidemiology of SARS Animal and environmental reservoirs Farms: raising and slaughtering of infected animals like unlucky palm civets Might SARS-CoV recombine with other strains of the coronavirus? NO not likely! Onset of illness Incubation period: 4 to 6 days Infectious period is very dangerous if not treated right away leads to death of infected person/animal Transmission Close contact – droplet, fomites, direct contact Airborne Fecal-oral

Latest on Morbidity and Mortality Reports “Scientists test blood in Beijing. China's government announced that a vaccine for Severe Acute Respiratory Syndrome (SARS) had emerged from the first phase clinical test as both safe and effective.” 2(Right) “An infrared thermograph system at Tokyo airport. French airport authorities are planning to experiment with heat-detecting cameras to identify passengers with a fever as part of efforts to combat the spread of infectious diseases, like SARS and bird flu.(AFP/JIJI Press)” 2(Left)

Latest on Morbidity and Mortality Reports “SARS Molecular Detection External Quality assurance: Commercial Test kit used to perform tests on inactivated severe acute respiratory syndrome associated Coronavrius significantly improved the outcome. 3 Reference material has been created for the fist time in this study which can be obtained from WHO (World Health Organization). 3 Figure:" Probity analysis of the fractions of laboratories achieving a positive result (y-axis) in relation to the virus RNA concentration in a given positive sample (x-axis). Data points represent individual samples in proficiency test panel. The thick line is the regression line calculated on the basis of a probity model (dose-response curve); the thin lines are 95% confidence intervals. Data fit into the model with p < ” 3

At the Present time “Currently, there is no known SARS transmission anywhere in the world. The most recent human cases of SARS-CoV infection were reported in China in April 2004 in an outbreak resulting from laboratory-acquired infections (see link for more details). CDC and its partners, including the World Health Organization, continue to monitor the SARS situation globally.” CDC QUESTIONS!!!!!!

References 1. “Consensus document on the epidemiology of severe acute respiratory syndrome (SARS).” World Health Organization 2003., December 5, “China says first SARS vaccine ‘safe and effective’” agence France presse December 5, Dorsten. C., Doerr. H., Lim. W., Stohr. K., Niedrig. M., “SARS Molecular Detection External Quality Assurance.” Emerging Infectious Diseases Vol. 10, No. 12, December “Current SARS Situation” Centers for Disease Control and Prevention December 5, Prescott. L., Harley.J., Klein. D, “Microbiology” McGraw Hill Inc Dr. Alan Cann, “Coronaviruses” Microbiology & Immunology “Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2” Centers for Disease Control and Prevention, January 8, “Map of Guangdong.” Muztagh Travel, December 4,